| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/01/2009 | US20090005301 207 Human Secreted Proteins |
| 01/01/2009 | US20090005297 Aprotinin Variants |
| 01/01/2009 | US20090005261 Purification of immunoglobulins using affinity chromatography and peptide ligands |
| 01/01/2009 | US20090005257 Process for Recovering Polypeptides that Unfold Reversibly from a Polypeptide Repertoire |
| 01/01/2009 | US20090004734 Mutated Anti-CD22 Antibodies With Increased Affinity To CD22-Expressing Leukemia Cells |
| 01/01/2009 | US20090004719 Protein-protein interactions in human immunodeficiency virus |
| 01/01/2009 | US20090004689 Lineage Restricted Glial Precursors from the Central Nervous System |
| 01/01/2009 | US20090004687 Predictive markers for ovarian cancer |
| 01/01/2009 | US20090004683 Indicator Agent for Noninflammatory Stress Response and Use Thereof |
| 01/01/2009 | US20090004676 T1R3 receptor binding assays for identification of taste modulatory compounds |
| 01/01/2009 | US20090004674 ACPL-related assays |
| 01/01/2009 | US20090004672 17867, a novel human aminopeptidase |
| 01/01/2009 | US20090004670 Methods for fabricating surface enhanced fluorescent (sef) nanoparticles and their applications in bioassays |
| 01/01/2009 | US20090004669 Methods of diagnosing pre-eclampsia or eclampsia |
| 01/01/2009 | US20090004648 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer |
| 01/01/2009 | US20090004647 AT-binding transcription factor 1 (ATBF-1); zinc finger homeobox protein; immunohistochemical staining |
| 01/01/2009 | US20090004264 Methods for treating and ameliorating the symptons of inflammatory bowel diseases |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004206 Polynucleotides and Polypeptide Sequences Involved in the Process of Bone Remodeling |
| 01/01/2009 | US20090004203 Methods of treating measles infectious disease in mammals |
| 01/01/2009 | US20090004200 Combination treatment of pancreatic cancer |
| 01/01/2009 | US20090004199 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 01/01/2009 | US20090004198 Human monoclonal antibody binding to human cytomegalovirus and its antigen binding portion |
| 01/01/2009 | US20090004194 Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity |
| 01/01/2009 | US20090004192 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 01/01/2009 | US20090004188 antibody that specifically binds to a human TNF Receptor in the BRAIN (TRAIN) polypeptide; useful in regulating cell differentiation, death, and survival |
| 01/01/2009 | US20090004186 Effector function enhanced recombinant antibody composition |
| 01/01/2009 | US20090004183 Compositions and Methods for Regulating the Alternative Pathway of Complement |
| 01/01/2009 | US20090004181 Method for Modulating Appetite |
| 01/01/2009 | US20090004179 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 01/01/2009 | US20090004162 Hecgf-1 Related Polymorphisms and Applications Thereof |
| 01/01/2009 | US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE |
| 01/01/2009 | US20090004118 Multifunctional Nanoparticle Conjugates And Their Use |
| 01/01/2009 | US20090004109 Antibodies and Molecules Derived Therefrom that Bind to Steap-1 Proteins |
| 01/01/2009 | US20090004103 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 01/01/2009 | US20090004102 HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 12/31/2008 | WO2009003019A1 Methods of treating rsv infections and related conditions |
| 12/31/2008 | WO2009002993A1 Conjugates containing hydrophilic spacer linkers |
| 12/31/2008 | WO2009002939A2 Autophilic antibodies |
| 12/31/2008 | WO2009002790A2 Compositions and methods for treating, reducing, ameliorating, alleviating, or preventing dry eye |
| 12/31/2008 | WO2009002193A1 Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof |
| 12/31/2008 | WO2009001840A1 Anti-prominin-1 antibody having adcc activity or cdc activity |
| 12/31/2008 | WO2009001392A1 Gene codifying for ambra 1 protein which regulates autophagv and the development of the central nervous system |
| 12/31/2008 | WO2009001141A1 Detection of cell surface binding molecules using a phage display blocking assay |
| 12/31/2008 | WO2009000894A1 Anti-vpac1 antibodies and their uses |
| 12/31/2008 | WO2009000539A1 Modulation of production of retroviruses by apobec4 |
| 12/31/2008 | WO2009000406A1 Use of antibodies against the cd52 antigen for the treatment of neurological disorders, particularly transmissible spongiform encephalopathy and alzheimer's disease |
| 12/31/2008 | WO2009000099A2 Methods of modifying antibodies, and modified antibodies with improved functional properties |
| 12/31/2008 | WO2009000098A2 Sequence based engineering and optimization of single chain antibodies |
| 12/31/2008 | WO2009000077A1 Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof |
| 12/31/2008 | WO2009000006A1 Display of binding agents |
| 12/31/2008 | WO2008137838A3 Interferon alpha-induced pharmacodynamic markers |
| 12/31/2008 | WO2008135419A3 Anti-il-6-agents for improving primary functioning of allogenic grafts |
| 12/31/2008 | WO2008134538A3 Antibodies to human somatostatin receptor and methods of use |
| 12/31/2008 | WO2008133873A9 Fgf-binding fusion proteins |
| 12/31/2008 | WO2008126065A3 Polynucleotides and polypeptides involved in gestational malaria, and biological applications |
| 12/31/2008 | WO2008125985A3 Blocking interaction between pathogen factors and factor h to inhibit hemorrhagic syndromes |
| 12/31/2008 | WO2008116118A3 Fully human antibodies to gram positive bacteria |
| 12/31/2008 | WO2008112891A3 Monoclonal antibody that recognizes a seneca valley virus (svv) cellular receptor and uses thereof |
| 12/31/2008 | WO2008112290A3 Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer |
| 12/31/2008 | WO2008103905A3 Antibodies that specifically bind irta and methods of use |
| 12/31/2008 | WO2008097585A3 Mutations in human ubiad1 |
| 12/31/2008 | WO2008092117A3 Immunoglobulins with modifications in the fcr binding region |
| 12/31/2008 | WO2008091954B1 Optimized cd40 antibodies and methods of using the same |
| 12/31/2008 | WO2008091954A4 Optimized cd40 antibodies and methods of using the same |
| 12/31/2008 | WO2008090319A3 Methods and biomarkers for diagnosing and monitoring psychotic disorders |
| 12/31/2008 | WO2008064094A3 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof |
| 12/31/2008 | WO2008044068A3 Combination therapy |
| 12/31/2008 | WO2008013914A3 Compositions and methods for diagnosing patients with acute atherosclerotic syndromes |
| 12/31/2008 | WO2007140431A3 Novel bioactive lipid derivatives, immune-derived moieties reactive thereto, and methods of making and using the same |
| 12/31/2008 | WO2007129895A3 Deimmunized antagonistic anti-human cd40 monoclonal antibody from the ch5d12 antibody |
| 12/31/2008 | EP2009445A1 Use of a camelid single-domain antibody for detecting an oligomeric form of an amyloid beta peptide and its applications |
| 12/31/2008 | EP2009105A1 Novel serotype Streptococcus mutans and utilization of the same |
| 12/31/2008 | EP2009104A1 Phosphorylation epitopes of Tau protein for the diagnosis and treatment of Alzheimer's disease |
| 12/31/2008 | EP2009102A2 Random mutagenesis and amplification of nucleic acid |
| 12/31/2008 | EP2009101A1 Antibody modification method for purifying bispecific antibody |
| 12/31/2008 | EP2009097A1 Normal prostate stem cells |
| 12/31/2008 | EP2009094A1 Fusion partner cells |
| 12/31/2008 | EP2009028A1 Combination of a conventional anti-cancer treatment with anti-CD44 antibody administration for treating solid tumors |
| 12/31/2008 | EP2009027A1 Anti-CD40 monoclonal antibody |
| 12/31/2008 | EP2009026A1 Anti-VPAC1 antibodies and their uses |
| 12/31/2008 | EP2007899A2 Antibodies directed to angiopoietin-like protein 4 and uses thereof |
| 12/31/2008 | EP2007814A2 Single domain vhh antibodies against von willebrand factor |
| 12/31/2008 | EP2007813A2 Agonist erythropoietin receptor antibodies |
| 12/31/2008 | EP2007812A2 Erythropoietin receptor agonists |
| 12/31/2008 | EP2007811A2 Targeted binding agents directed to upar and uses thereof |
| 12/31/2008 | EP2007810A2 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 12/31/2008 | EP2007809A1 Glycosylated antibodies |
| 12/31/2008 | EP2007808A2 Binding proteins comprising immunoglobulin hinge and fc regions having altered fc effector functions |
| 12/31/2008 | EP2007807A2 Composition and method for mediating an immune response |
| 12/31/2008 | EP2007538A2 Binding partners with immunoglobulin domains modified to have extended half-life |
| 12/31/2008 | EP2007435A2 System for targeted delivery of therapeutic agents |
| 12/31/2008 | EP2007425A2 Methods for treating conditions associated with masp-2 dependent complement activation |
| 12/31/2008 | EP2007424A2 Tumor cell differentiation agents as chemical inhibitors and treatments for intracellular parasites |
| 12/31/2008 | EP2007423A2 Ctla4 antibody combination therapy |
| 12/31/2008 | EP2007418A1 Reversibly inhibited antibodies for immune cell stimulation |
| 12/31/2008 | EP1842065A4 Methods for diagnosis and prognosis of epithelial cancers |
| 12/31/2008 | EP1718760B1 Protein phosphorylation in c-src signaling pathways |
| 12/31/2008 | EP1660536B1 FACTOR IXa SPECIFIC ANTIBODIES DISPLAYING FACTOR VIIIa LIKE ACTIVITY |
| 12/31/2008 | EP1551976B1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |